Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening.

Gynecologic oncology

Volumn 88, Issue 1 Pt 2, 2003, Pages

  Whitehouse, Caroline ^a   Solomon, Ellen ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

BIOSYNTHESIS; BLOOD; CHEMISTRY; FEMALE; FORECASTING; GENETICS; HUMAN; MASS SCREENING; METHODOLOGY; OVARY TUMOR; REVIEW;

CA-125 ANTIGEN; FEMALE; FORECASTING; HUMANS; MASS SCREENING; OVARIAN NEOPLASMS;

MLCS; MLOWN;

EID: 0037263967     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6708     Document Type: Review

References (62)